20/20 Biolabs, Inc. (AIDX) - Latest Market Data

Price & Market Data

Price: $1.02

Daily Change: -$0.185 / 18.14%

Daily Range: $0.90 - $1.56

Market Cap: $10,270,487

Daily Volume: 9,413,828

Performance Metrics

1 Week: -24.31%

1 Month: -42.92%

3 Months: -94.73%

6 Months: -97.96%

1 Year: -97.96%

YTD: -97.96%

About 20/20 Biolabs, Inc. (AIDX)

Financial insights into 20/20 Biolabs, Inc. (AIDX). Current price: 1.02, daily change: -$0.185 / 18.14%. Market cap: 10,270,487. Performance metrics across all timeframes are updated.

Company Details

Employees: 14

Sector: Health services

Industry: Medical/Nursing services

Country: United States

Details

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.

Selected stocks

Greenland Technologies Holding Corporation (GTEC)

Enhanced Group Inc. (ENHA)

Lucas GC Limited (LGCL)

Bit Digital, Inc. (BTBT)